Jason Denbo
Overview
Explore the profile of Jason Denbo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serenari M, Berti D, Rivera B, Newhook T, Kristjanpoller W, Ruzzenente A, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40050485
Background: Gallbladder cancer (GBC) has a poor prognosis, particularly in advanced stages, with surgery often offering limited survival benefit. This study aimed to identify risk factors for futile surgery (FS),...
2.
Yu J, He A, Ouf M, Mehta R, Anaya D, Denbo J, et al.
JCO Precis Oncol
. 2025 Jan;
9():e2400443.
PMID: 39772829
Purpose: This study aimed to assess (1) the prognostic value of circulating tumor DNA (ctDNA) and (2) the ability of ctDNA to detect recurrence compared with standard surveillance in curatively...
3.
Stokes S, Haider M, Vadaparampil S, Levitt C, Hardy O, Kim R, et al.
PEC Innov
. 2024 Jan;
4:100248.
PMID: 38292078
Objective: Hepatobiliary tumors have evolving management guidelines. Patient educational needs and interest in community engagement are unknown. This study serves as a needs assessment. Methods: A prospective, needs assessment, survey...
4.
Chang J, Hossain M, Stackhouse K, Dahdaleh F, Denbo J, Augustin T, et al.
HPB (Oxford)
. 2023 Jun;
25(10):1213-1222.
PMID: 37357114
Background: In distal pancreatectomy (DP) for pancreatic ductal adenocarcinoma (PDAC), we hypothesize that minimally invasive DP (MIDP) carries short-term benefits over ODP (ODP) in the absence of postoperative pancreatic fistula...
5.
Palm R, Boyer E, Kim D, Denbo J, Hodul P, Malafa M, et al.
HPB (Oxford)
. 2023 Jun;
25(9):1110-1120.
PMID: 37286392
Background: The influence of chemotherapy type and vascular margin status after sequential chemotherapy and stereotactic body radiation therapy (SBRT) for borderline resectable pancreatic cancer (BRPC) is unknown. Methods: A retrospective...
6.
Bryant J, Palm R, Herrera R, Rubens M, Hoffe S, Kim D, et al.
Cancer Control
. 2023 Jan;
30:10732748221150228.
PMID: 36598464
Purpose: Treatment options for pancreatic ductal adenocarcinoma (PDAC) are commonly limited for patients with advanced age due to medical comorbidities and/or poor performance status. These patients may not be candidates...
7.
Bryant J, Palm R, Liveringhouse C, Boyer E, Hodul P, Malafa M, et al.
Adv Radiat Oncol
. 2022 Nov;
7(6):101045.
PMID: 36420193
Purpose: Preoperative radiation therapy (RT) for pancreatic adenocarcinoma reduces positive surgical margin rates, and when delivered to an ablative dose range it may improve local control and overall survival for...
8.
Rothermel L, Denbo J, Anaya D
J Gastrointest Surg
. 2022 May;
26(9):2024-2028.
PMID: 35606600
No abstract available.
9.
Allenson K, Turner K, Gonzalez B, Gurd E, Zhu S, Misner N, et al.
BMC Nutr
. 2021 Dec;
7(1):82.
PMID: 34886909
Background: Patients undergoing hepatopancreatobiliary (HPB) surgery, such patients with pancreatic, periampullary, and liver cancer, are at high risk for malnutrition. Malnutrition increases surgical complications and reduces overall survival. Despite its...
10.
Ehab J, Powers B, Kim R, Haider M, Utuama O, Chin A, et al.
Ann Surg Oncol
. 2021 Oct;
29(4):2371-2380.
PMID: 34671878
Background: Patients with hepatobiliary malignancies are especially vulnerable to treatment delays. This study sought to evaluate the impact of implementing a new delivery-of-care model centered around a hepatobiliary multidisciplinary tumor...